ClinConnect ClinConnect Logo
Search / Trial NCT06793163

Diagnosis and Allergen Identification of Perioperative Anaphylaxis

Launched by PEKING UNIVERSITY FIRST HOSPITAL · Jan 20, 2025

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Perioperative/Postoperative Complications Anaphylaxis Tryptase Allergens Skin Testing

ClinConnect Summary

This clinical trial is focused on understanding and identifying the causes of perioperative anaphylaxis, which is a severe allergic reaction that can happen during or after surgery. The researchers aim to improve how doctors can diagnose and manage these reactions by looking at a substance called serum tryptase, which can help confirm if an anaphylactic reaction has occurred. Additionally, the study will explore how skin testing can help identify specific allergens so that patients can avoid these triggers in future surgeries.

To participate in this trial, individuals must be at least 18 years old and either have experienced an allergic reaction during surgery or have a history of suspected reactions in the operating room. Participants will undergo tests to help identify any allergens they may be sensitive to. It's important to note that this trial is not yet recruiting participants, and anyone who is interested will need to meet specific eligibility criteria to join. Overall, this study aims to enhance safety and care for patients undergoing surgery by better understanding allergic reactions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged 2 years or over;
  • Suspected anaphylaxis in the operating rooms, or history of suspected anaphylaxis in the operating room.
  • Exclusion Criteria:
  • Refuse to participate;
  • Other conditions that are considered unsuitable for study participation.

About Peking University First Hospital

Peking University First Hospital is a leading medical institution in China, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its extensive expertise in various medical fields to conduct rigorous studies aimed at improving patient outcomes and contributing to global medical knowledge. With a multidisciplinary team of skilled researchers and clinicians, Peking University First Hospital is dedicated to the ethical conduct of clinical research, ensuring the highest standards of safety and efficacy in its trials. The institution plays a vital role in translating scientific discoveries into effective treatments, thereby enhancing the quality of care for patients both locally and worldwide.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Dong-Xin Wang, MD, PhD

Principal Investigator

Peking University First Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported